Withdrawal of immunosuppressive therapy after developing melanoma [7]

Journal of the American Academy of Dermatology

Volumn 50, Issue 5, 2004, Pages 802-

  Sorscher, Steven M ^a  

^a MARSHFIELD CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOSUPPRESSIVE AGENT;

ADULT; CANCER RECURRENCE; CASE REPORT; DRUG WITHDRAWAL; HIGH RISK PATIENT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; LETTER; MELANOMA; PRIORITY JOURNAL; PROGNOSIS;

EID: 2342656455     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0190-9622(03)02158-3     Document Type: Letter

References (4)

1. Berg D, Otley CC. Skin cancer in organ transplant recipients: Epidemiology, pathogenesis, and management. J Am Acad Dermatol 2002;47:1-17.
2. Meenhard H, Satyamoorthy K. Melanoma. In: DeVita VT, Hellman S, Rosenberg SA, editors. Cancer: Principles and practice of oncology. Philadelphia: Lippincott Williams and Williams; 2001. p. 2003-69.
3. MacKie RM, Reid R. Fatal melanoma transferred in a donated kidney 16 years after melanoma surgery. N Engl J Med 2003;348: 567-8.
4. Penn I. Malignant melanoma in organ allograft recipients. Transplantation 1996;61:274-8.